NL8603209A - Nieuwe celgroei-regulerende factor. - Google Patents
Nieuwe celgroei-regulerende factor. Download PDFInfo
- Publication number
- NL8603209A NL8603209A NL8603209A NL8603209A NL8603209A NL 8603209 A NL8603209 A NL 8603209A NL 8603209 A NL8603209 A NL 8603209A NL 8603209 A NL8603209 A NL 8603209A NL 8603209 A NL8603209 A NL 8603209A
- Authority
- NL
- Netherlands
- Prior art keywords
- polypeptide
- amino acid
- cells
- sequence
- poly
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
- C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Gastroenterology & Hepatology (AREA)
- Microbiology (AREA)
- Toxicology (AREA)
- General Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Saccharide Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US81123585A | 1985-12-20 | 1985-12-20 | |
US81123585 | 1985-12-20 | ||
US93528386A | 1986-11-26 | 1986-11-26 | |
US93528386 | 1986-11-26 |
Publications (1)
Publication Number | Publication Date |
---|---|
NL8603209A true NL8603209A (nl) | 1987-07-16 |
Family
ID=27123452
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NL8603209A NL8603209A (nl) | 1985-12-20 | 1986-12-17 | Nieuwe celgroei-regulerende factor. |
Country Status (29)
Country | Link |
---|---|
JP (1) | JP2559035B2 (pt) |
KR (1) | KR920005920B1 (pt) |
CN (1) | CN1017626B (pt) |
AT (1) | AT400444B (pt) |
AU (2) | AU601168B2 (pt) |
BE (1) | BE905957A (pt) |
CA (1) | CA1340296C (pt) |
CH (1) | CH675727A5 (pt) |
CY (1) | CY1608A (pt) |
DE (2) | DE3645095C2 (pt) |
DK (1) | DK174094B1 (pt) |
ES (1) | ES2003180A6 (pt) |
FI (1) | FI91484C (pt) |
FR (1) | FR2597108B1 (pt) |
GB (1) | GB2185485B (pt) |
GR (1) | GR862936B (pt) |
HK (1) | HK65691A (pt) |
HU (1) | HU210694B (pt) |
IE (1) | IE59415B1 (pt) |
IL (1) | IL81017A (pt) |
IT (1) | IT1213428B (pt) |
LU (1) | LU86718A1 (pt) |
NL (1) | NL8603209A (pt) |
NO (1) | NO174556C (pt) |
NZ (1) | NZ218634A (pt) |
OA (1) | OA08494A (pt) |
PT (1) | PT83986B (pt) |
SE (1) | SE505059C2 (pt) |
SG (1) | SG60891G (pt) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0315289A2 (en) * | 1987-11-06 | 1989-05-10 | Oncogen | Cell growth inhibitory factor |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4645828A (en) * | 1984-03-23 | 1987-02-24 | Oncogen | Platelet related growth regulator |
US5681930A (en) * | 1985-12-20 | 1997-10-28 | Bristol-Myers Squibb Company | Anti-oncostatin M monoclonal antibodies |
NZ218634A (en) * | 1985-12-20 | 1991-06-25 | Oncogen | Peptide identified by its cross reactivity with a cell growth factor, dna, antibodies to peptide and test kits |
IL97623A (en) * | 1990-03-29 | 1996-01-19 | Bristol Myers Squibb Co | Monoclonal antibodies against oncostatin M, their preparation and pharmaceutical preparations containing them |
IL97622A (en) * | 1990-03-29 | 1997-06-10 | Oncogen Limited Partnership Se | Monoclonal antibodies that inhibit growth of kaposi's sarcoma |
WO1992002556A1 (en) * | 1990-08-02 | 1992-02-20 | Michael Valentine Agrez | Human colon cancer cell-derived fibroblast elongation factor |
CZ195193A3 (en) * | 1992-09-25 | 1994-04-13 | Lilly Co Eli | Modified factor-4 of blood platelets, process of its preparation and pharmaceutical preparation in which it is comprised |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4132776A (en) * | 1978-02-15 | 1979-01-02 | University Patents, Inc. | Delivery of immunologically active components of transfer factor |
US4645828A (en) * | 1984-03-23 | 1987-02-24 | Oncogen | Platelet related growth regulator |
NZ218634A (en) * | 1985-12-20 | 1991-06-25 | Oncogen | Peptide identified by its cross reactivity with a cell growth factor, dna, antibodies to peptide and test kits |
-
1986
- 1986-12-15 NZ NZ218634A patent/NZ218634A/en unknown
- 1986-12-16 GB GB8629997A patent/GB2185485B/en not_active Expired - Lifetime
- 1986-12-16 AU AU66608/86A patent/AU601168B2/en not_active Expired
- 1986-12-17 NL NL8603209A patent/NL8603209A/nl not_active Application Discontinuation
- 1986-12-17 FI FI865156A patent/FI91484C/fi not_active IP Right Cessation
- 1986-12-17 LU LU86718A patent/LU86718A1/fr unknown
- 1986-12-17 ES ES8603468A patent/ES2003180A6/es not_active Expired
- 1986-12-17 BE BE0/217546A patent/BE905957A/fr not_active IP Right Cessation
- 1986-12-18 DK DK198606153A patent/DK174094B1/da not_active IP Right Cessation
- 1986-12-18 IL IL81017A patent/IL81017A/xx not_active IP Right Cessation
- 1986-12-18 CA CA000525706A patent/CA1340296C/en not_active Expired - Lifetime
- 1986-12-18 SE SE8605459A patent/SE505059C2/sv not_active IP Right Cessation
- 1986-12-19 KR KR1019860010968A patent/KR920005920B1/ko not_active IP Right Cessation
- 1986-12-19 CN CN86108955A patent/CN1017626B/zh not_active Expired
- 1986-12-19 OA OA59026A patent/OA08494A/xx unknown
- 1986-12-19 IE IE334586A patent/IE59415B1/en not_active IP Right Cessation
- 1986-12-19 HU HU865359A patent/HU210694B/hu unknown
- 1986-12-19 JP JP61301853A patent/JP2559035B2/ja not_active Expired - Lifetime
- 1986-12-19 DE DE3645095A patent/DE3645095C2/de not_active Expired - Lifetime
- 1986-12-19 DE DE19863643428 patent/DE3643428A1/de active Granted
- 1986-12-19 IT IT8622787A patent/IT1213428B/it active
- 1986-12-19 NO NO865178A patent/NO174556C/no not_active IP Right Cessation
- 1986-12-19 FR FR868617895A patent/FR2597108B1/fr not_active Expired - Lifetime
- 1986-12-19 PT PT83986A patent/PT83986B/pt unknown
- 1986-12-22 GR GR862936A patent/GR862936B/el unknown
- 1986-12-22 CH CH5119/86A patent/CH675727A5/de unknown
- 1986-12-22 AT AT0340686A patent/AT400444B/de not_active IP Right Cessation
-
1990
- 1990-12-05 AU AU67765/90A patent/AU639048B2/en not_active Ceased
-
1991
- 1991-07-25 SG SG608/91A patent/SG60891G/en unknown
- 1991-08-15 HK HK656/91A patent/HK65691A/xx not_active IP Right Cessation
-
1992
- 1992-04-03 CY CY1608A patent/CY1608A/xx unknown
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0315289A2 (en) * | 1987-11-06 | 1989-05-10 | Oncogen | Cell growth inhibitory factor |
EP0315289A3 (en) * | 1987-11-06 | 1990-04-11 | Oncogen | Cell growth inhibitory factor |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Williams et al. | Identification of a ligand for the c-kit proto-oncogene | |
Pober et al. | Two distinct monokines, interleukin 1 and tumor necrosis factor, each independently induce biosynthesis and transient expression of the same antigen on the surface of cultured human vascular endothelial cells. | |
JP3088983B2 (ja) | 上皮細胞に特異的な成長因子をコードするdna | |
Levy et al. | An endothelial cell growth factor from the mouse neuroblastoma cell line NB41 | |
FI120312B (fi) | Ihmisen kantasolutekijän valmistamiseksi soveltuva solu | |
CA2210644A1 (en) | Ligands for eph-like receptors | |
NL8900178A (nl) | Groei regulerende clycoproteinen. | |
CN112386678B (zh) | 多肽或其衍生物的应用 | |
CN1425066B (zh) | 新的stra6多肽 | |
Miyazono et al. | Platelet-derived endothelial cell growth factor | |
JPH03195496A (ja) | 成長因子 | |
NL8603209A (nl) | Nieuwe celgroei-regulerende factor. | |
Deuel et al. | Platelet‐derived growth factor/sis in normal and neoplastic cell growth | |
Ginsburg et al. | Stimulation of growth of human breast cancer cells (T47D) by platelet derived growth factor | |
Braunhut et al. | Expression of fibroblast growth factor by F9 teratocarcinoma cells as a function of differentiation. | |
Valente et al. | Cultured primate aortic smooth muscle cells express both the PDGF‐‐A and PDGF‐B genes but do not secrete mitogenic activity or dimeric platelet‐derived growth factor protein | |
US5262298A (en) | Method to assess the ability of a substance to inhibit or stimulate keratinocyte autocrine factor production | |
Newcom et al. | High molecular weight transforming growth factor β is excreted in the urine in active nodular sclerosing Hodgkin's disease | |
Witte et al. | Growth factor production by a human megakaryocytic tumor cell line | |
Pennington et al. | Dog mastocytoma cells secrete a growth factor for fibroblasts | |
US5071956A (en) | Protein with vascular activity derived from monocytes and its analogues, a process for its extraction and their uses for therapeutic purposes and for the preparation of antibodies | |
US5147798A (en) | Monophenotypic xenograft of megakaryocytic lineage and origin | |
FI98373B (fi) | Uusi diagnostisesti käyttökelpoinen polypeptidi, onkostatiini M | |
AU630873B2 (en) | Lung growth stimulatory and inhibitory factors for carcinoma tumor cells | |
Kelley | Platelet-Derived Growth Factor, Transforming Growth Factor-β and Connective Tissue Growth Factor |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
BT | A notification was added to the application dossier and made available to the public | ||
BA | A request for search or an international-type search has been filed | ||
BB | A search report has been drawn up | ||
BC | A request for examination has been filed | ||
BV | The patent application has lapsed |